US Stock MarketDetailed Quotes

AUTL Autolus Therapeutics

Watchlist
  • 3.510
  • -0.220-5.90%
Close Nov 11 16:00 ET
  • 3.590
  • +0.080+2.28%
Post 20:02 ET
933.99MMarket Cap-3078P/E (TTM)

About Autolus Therapeutics Company

Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.

Company Profile

SymbolAUTL
Company NameAutolus Therapeutics
Listing DateJun 22, 2018
Issue Price17.00
Founded2018
CEODr. Christian Itin, PhD.
MarketNASDAQ
Employees471
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressThe Mediaworks,191 Wood Lane,White City
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW12 7FP
Phone44-20-3829-6230
Websitehttp://www.autolus.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Christian Itin, PhD.
  • Chief Executive Officer and Director
  • 1.92M
  • Martin Pule
  • Senior Vice President and Chief Scientific Officer
  • --
  • Robert F. Dolski
  • Senior Vice President, Chief Financial Officer
  • --
  • David Brochu
  • Senior Vice President and Chief Technical Officer
  • --
  • Christopher Vann
  • Senior Vice President and Chief Operating Officer
  • --
  • Dr. Christopher Willia PhD
  • Senior Vice President and Chief Business Development Officer
  • --
  • Brent Rice
  • Senior Vice President and Chief Commercial Officer
  • --
  • Alexander Swan
  • Senior Vice President, Chief Human Resources Officer
  • --
  • Dr. Edgar Braendle
  • Senior Vice President and Chief Development Officer
  • --
  • Michael W. Bonney
  • Chairman of the Board
  • --
  • Dr. Elisabeth Leiderman, M.D.
  • Director
  • 12.73K
  • Dr. Ravi Madduri Rao
  • Director
  • --
  • Robert W. Azelby
  • Director
  • --
  • Linda C. Bain
  • Independent Director
  • 169.52K
  • Dr. Martin Murphy, PhD
  • Independent Director
  • 158.28K
  • William D. Young
  • Independent Director
  • 175.82K
  • Dr. Joseph Anderson, PhD.
  • Independent Director
  • 195.65K
  • Cynthia M. Butitta
  • Independent Director
  • 164.65K
  • John E. Berriman
  • Independent Director
  • 163.15K
  • Dr. Robert Iannone, M.D.
  • Independent Director
  • 134.86K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data